Challenges of autologous therapies

Cell therapy clinical trials, especially autologous trials, are extremely complex undertakings with an abundance of moving parts and ample opportunities for miscommunication or unexpected delays. In order to ensure the success of an autologous cell therapy trial, a tremendous effort must be put forth in overcoming these challenges.  You will have to log in or register to view the full content.
Choose language »